Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02290834 · ClinicalTrials.gov registry record · NA

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

A NA study of Breast Cancer and Impaired Cognition, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT02290834: Recruiting NA study of Breast Cancer and Impaired Cognition, sponsored by Massachusetts General Hospital.

NCT02290834 is a NA study of Breast Cancer and Impaired Cognition that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 200 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02290834, a NA study of Breast Cancer and Impaired Cognition, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

This research study evaluates the effect of chemotherapy on cognition (thinking) and the brain in people with breast cancer.

Interventions

  • DEVICE MRI
  • OTHER Cognitive, functional and subjective assessments
  • RADIATION PET Scan

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Massachusetts General Hospital/North Shore Cancer Center - Salem

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2015-03
Est. Completion 2028-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT02290834 shows while recruiting

NCT02290834 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which MRI is the first listed.

NCT02290834 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02290834 about?

NCT02290834 is a clinical study titled "Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer". This research study evaluates the effect of chemotherapy on cognition (thinking) and the brain in people with breast cancer.

What is the current status of trial NCT02290834?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2015-03. Estimated completion is 2028-01.

What conditions does trial NCT02290834 study?

This clinical trial studies the following conditions: Breast Cancer, Impaired Cognition, Chemo-brain.

What interventions are being tested in trial NCT02290834?

The interventions under investigation include: MRI (DEVICE), Cognitive, functional and subjective assessments (OTHER), PET Scan (RADIATION).

Who is sponsoring clinical trial NCT02290834?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02290834 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02290834's enrollment target sits among peer trials

200 362nd of 1224 higher than 841 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02290834, the US trial registry maintained by the National Library of Medicine. NCT02290834 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.